{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,30]],"date-time":"2026-05-30T12:12:51Z","timestamp":1780143171934,"version":"3.54.0"},"reference-count":49,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,6,29]],"date-time":"2022-06-29T00:00:00Z","timestamp":1656460800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,6,29]],"date-time":"2022-06-29T00:00:00Z","timestamp":1656460800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100002855","name":"Ministry of Science and Technology of the People's Republic of China","doi-asserted-by":"publisher","award":["2019YFC0118600"],"award-info":[{"award-number":["2019YFC0118600"]}],"id":[{"id":"10.13039\/501100002855","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81971011"],"award-info":[{"award-number":["81971011"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Beijing Municipal Science and Technology Committee","award":["D171100008217005, 7202060"],"award-info":[{"award-number":["D171100008217005, 7202060"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Alz Res Therapy"],"published-print":{"date-parts":[[2022,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>To elucidate the clinical and ancillary features of genetic prion diseases (gPrDs) presenting with frontotemporal dementia (FTD) to aid early identification.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>Global data of gPrDs presenting with FTD caused by prion protein gene mutations were collected from literature review and our records. Fifty-one cases of typical FTD and 136 cases of prion diseases admitted to our institution were included as controls. Clinical and ancillary data of the different groups were compared.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Forty-nine cases of gPrDs presenting with FTD were identified. Compared to FTD or prion diseases, gPrDs presenting with FTD were characterized by earlier onset age (median 45 vs. 61\/60 years, <jats:italic>P<\/jats:italic> &lt; 0.001, <jats:italic>P<\/jats:italic> &lt; 0.001) and higher incidence of positive family history (81.6% vs. 27.5\/13.2%, <jats:italic>P<\/jats:italic> &lt; 0.001, <jats:italic>P<\/jats:italic> &lt; 0.001). Furthermore, GPrDs presenting with FTD exhibited shorter duration (median 5 vs. 8 years) and a higher rate of parkinsonism (63.7% vs. 9.8%, <jats:italic>P<\/jats:italic> &lt; 0.001), pyramidal signs (39.1% vs. 7.8%, <jats:italic>P<\/jats:italic> = 0.001), mutism (35.9% vs. 0%, <jats:italic>P<\/jats:italic> &lt; 0.001), seizures (25.8% vs. 0%, <jats:italic>P<\/jats:italic> &lt; 0.001), myoclonus (22.5% vs. 0%, <jats:italic>P<\/jats:italic> &lt; 0.001), and hyperintensity on MRI (25.0% vs. 0, <jats:italic>P<\/jats:italic> &lt; 0.001) compared to FTD. Compared to prion diseases, gPrDs presenting with FTD had a longer duration of symptoms (median 5 vs. 1.1 years, <jats:italic>P<\/jats:italic> &lt; 0.001), higher rates of frontotemporal atrophy (89.7% vs. 3.3%, <jats:italic>P<\/jats:italic> &lt; 0.001), lower rates of periodic short-wave complexes on EEG (0% vs. 30.3%, <jats:italic>P<\/jats:italic> = 0.001), and hyperintensity on MRI (25.0% vs. 83.0%, <jats:italic>P<\/jats:italic> &lt; 0.001). The frequency of codon 129 Val allele in gPrDs presenting with FTD was significantly higher than that reported in the literature for gPrDs in the Caucasian and East Asian populations (33.3% vs. 19.2%\/8.0%, <jats:italic>P<\/jats:italic> = 0.005, <jats:italic>P<\/jats:italic> &lt; 0.001).<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>GPrDs presenting with FTD are characterized by early-onset, high incidence of positive family history, high frequency of the Val allele at codon 129, overlapping symptoms with prion disease and FTD, and ancillary features closer to FTD. <jats:italic>PRNP<\/jats:italic> mutations may be a rare cause in the FTD spectrum, and <jats:italic>PRNP<\/jats:italic> genotyping should be considered in patients with these features.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s13195-022-01033-4","type":"journal-article","created":{"date-parts":[[2022,6,29]],"date-time":"2022-06-29T13:04:58Z","timestamp":1656507898000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Genetic prion diseases presenting as frontotemporal dementia: clinical features and diagnostic challenge"],"prefix":"10.1186","volume":"14","author":[{"given":"Zhongyun","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min","family":"Chu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Kong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kexin","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yue","family":"Cui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong","family":"Ye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junjie","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liyong","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,6,29]]},"reference":[{"issue":"11","key":"1033_CR1","doi-asserted-by":"publisher","first-page":"1817","DOI":"10.1212\/01.wnl.0000187068.92184.63","volume":"65","author":"JS Goldman","year":"2005","unstructured":"Goldman JS, Farmer JM, Wood EM, et al. Comparison of family histories in FTLD subtypes and related tauopathies. Neurology. 2005;65(11):1817\u20139.","journal-title":"Neurology."},{"issue":"18","key":"1033_CR2","doi-asserted-by":"publisher","first-page":"1451","DOI":"10.1212\/WNL.0b013e3181bf997a","volume":"73","author":"JD Rohrer","year":"2009","unstructured":"Rohrer JD, Guerreiro R, Vandrovcova J, et al. The heritability and genetics of frontotemporal lobar degeneration. Neurology. 2009;73(18):1451\u20136.","journal-title":"Neurology."},{"issue":"16","key":"1033_CR3","doi-asserted-by":"publisher","first-page":"1220","DOI":"10.1212\/01.wnl.0000319702.37497.72","volume":"71","author":"H Seelaar","year":"2008","unstructured":"Seelaar H, Kamphorst W, Rosso SM, et al. Distinct genetic forms of frontotemporal dementia. Neurology. 2008;71(16):1220\u20136.","journal-title":"Neurology."},{"issue":"8","key":"1033_CR4","doi-asserted-by":"publisher","first-page":"2075","DOI":"10.1007\/s00415-019-09363-4","volume":"266","author":"CV Greaves","year":"2019","unstructured":"Greaves CV, Rohrer JD. An update on genetic frontotemporal dementia. J Neurol. 2019;266(8):2075\u201386.","journal-title":"J Neurol"},{"issue":"3","key":"1033_CR5","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1177\/1533317514545825","volume":"30","author":"AI Jarmolowicz","year":"2015","unstructured":"Jarmolowicz AI, Chen HY, Panegyres PK. The patterns of inheritance in early-onset dementia: Alzheimer\u2019s disease and frontotemporal dementia. Am J Alzheimers Dis Other Dement. 2015;30(3):299\u2013306.","journal-title":"Am J Alzheimers Dis Other Dement"},{"issue":"5-6","key":"1033_CR6","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1080\/21678421.2021.1880596","volume":"22","author":"Y Jiang","year":"2021","unstructured":"Jiang Y, Jiao B, Xiao X, et al. Genetics of frontotemporal dementia in China. Amyotroph Lateral Scler Frontotemporal Degener. 2021;22(5-6):321\u201335.","journal-title":"Amyotroph Lateral Scler Frontotemporal Degener"},{"issue":"11","key":"1033_CR7","doi-asserted-by":"publisher","first-page":"2657.e2657","DOI":"10.1016\/j.neurobiolaging.2014.06.006","volume":"35","author":"L Bernardi","year":"2014","unstructured":"Bernardi L, Cupidi C, Frangipane F, et al. Novel N-terminal domain mutation in prion protein detected in 2 patients diagnosed with frontotemporal lobar degeneration syndrome. Neurobiol Aging. 2014;35(11):2657.e2657\u201311.","journal-title":"Neurobiol Aging"},{"key":"1033_CR8","first-page":"18","volume":"28","author":"C Cupidi","year":"2013","unstructured":"Cupidi C, Bernardi L, Frangipane F, et al. Identification of the novel PRNP gene mutation PRO39LEU in patients affected by frontotemporal dementia. Funct Neurol. 2013;28:18.","journal-title":"Funct Neurol"},{"issue":"3","key":"1033_CR9","first-page":"124","volume":"37","author":"G Giaccone","year":"2018","unstructured":"Giaccone G, Indaco A, Moda F, et al. Neuropathological, biochemical, and prion protein aggregation properties of a patient with PRNP P39L variant clinically presenting as frontotemporal dementia. Clin Neuropathol. 2018;37(3):124.","journal-title":"Clin Neuropathol"},{"issue":"3","key":"1033_CR10","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1007\/s00401-005-1054-0","volume":"110","author":"J Woulfe","year":"2005","unstructured":"Woulfe J, Kertesz A, Frohn I, et al. Gerstmann-Straussler-Scheinker disease with the Q217R mutation mimicking frontotemporal dementia. Acta Neuropathol. 2005;110(3):317\u20139.","journal-title":"Acta Neuropathol"},{"issue":"7","key":"1033_CR11","doi-asserted-by":"publisher","first-page":"1304","DOI":"10.1212\/01.WNL.0000156911.70131.06","volume":"64","author":"DA Hall","year":"2005","unstructured":"Hall DA, Leehey MA, Filley CM, et al. PRNP H187R mutation associated with neuropsychiatric disorders in childhood and dementia. Neurology. 2005;64(7):1304\u20136.","journal-title":"Neurology."},{"issue":"1-2","key":"1033_CR12","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1016\/j.jns.2008.06.036","volume":"275","author":"F Clerici","year":"2008","unstructured":"Clerici F, Elia A, Girotti F, et al. Atypical presentation of Creutzfeldt-Jakob disease: The first Italian case associated with E196K mutation in the PRNP gene. J Neurol Sci. 2008;275(1-2):145\u20137.","journal-title":"J Neurol Sci"},{"issue":"9","key":"1033_CR13","doi-asserted-by":"publisher","first-page":"1165","DOI":"10.1001\/archneurol.2011.187","volume":"68","author":"N Kumar","year":"2011","unstructured":"Kumar N, Boeve BF, Boot BP, et al. Clinical characterization of a kindred with a novel 12-octapeptide repeat insertion in the prion protein gene. Arch Neurol. 2011;68(9):1165\u201370.","journal-title":"Arch Neurol"},{"issue":"2","key":"1033_CR14","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1111\/bpa.12083","volume":"24","author":"MA Riudavets","year":"2014","unstructured":"Riudavets MA, Sraka MA, Schultz M, et al. Gerstmann-Str\u00e4ussler-Scheinker syndrome with variable phenotype in a new kindred with PRNP -P102L mutation. Brain Pathol. 2014;24(2):142\u20137.","journal-title":"Brain Pathol"},{"issue":"6","key":"1033_CR15","first-page":"529","volume":"77","author":"B Ghetti","year":"2018","unstructured":"Ghetti B, Bonnin J, Garringer H, et al. Neurofibrillary tau pathology and PrP amyloidosis are associated with the PRNP Q160X nonsense mutation. J Neuropathol Exp Neurol. 2018;77(6):529\u201330.","journal-title":"J Neuropathol Exp Neurol"},{"issue":"5","key":"1033_CR16","doi-asserted-by":"crossref","first-page":"770.e771","DOI":"10.1016\/j.neurobiolaging.2005.05.025","volume":"27","author":"R Del Bo","year":"2006","unstructured":"Del Bo R, Scarlato M, Ghezzi S, et al. Is M129V of PRNP gene associated with Alzheimer\u2019s disease? A case-control study and a meta-analysis. Neurobiol Aging. 2006;27(5):770.e771\u20135.","journal-title":"Neurobiol Aging"},{"issue":"1-2","key":"1033_CR17","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/j.jns.2013.01.020","volume":"326","author":"J He","year":"2013","unstructured":"He J, Li X, Yang J, et al. The association between the methionine\/valine (M\/V) polymorphism (rs1799990) in the PRNP gene and the risk of Alzheimer disease: an update by meta-analysis. J Neurol Sci. 2013;326(1-2):89\u201395.","journal-title":"J Neurol Sci"},{"issue":"1","key":"1033_CR18","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1097\/WAD.0b013e3181eff695","volume":"25","author":"F Moreno","year":"2011","unstructured":"Moreno F, Alzualde A, Camblor PM, et al. Prion protein codon 129 polymorphism modifies age at onset of frontotemporal dementia with the C.709-1G>A progranulin mutation. Alzheimer Dis Assoc Disord. 2011;25(1):93\u20135.","journal-title":"Alzheimer Dis Assoc Disord"},{"issue":"2","key":"1033_CR19","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1016\/S1474-4422(10)70299-4","volume":"10","author":"O Piguet","year":"2011","unstructured":"Piguet O, Hornberger M, Mioshi E, et al. Behavioural-variant frontotemporal dementia: diagnosis, clinical staging, and management. Lancet Neurol. 2011;10(2):162\u201372.","journal-title":"Lancet Neurol"},{"issue":"11","key":"1033_CR20","doi-asserted-by":"publisher","first-page":"1006","DOI":"10.1212\/WNL.0b013e31821103e6","volume":"76","author":"ML Gorno-Tempini","year":"2011","unstructured":"Gorno-Tempini ML, Hillis AE, Weintraub S, et al. Classification of primary progressive aphasia and its variants. Neurology. 2011;76(11):1006\u201314.","journal-title":"Neurology."},{"issue":"5","key":"1033_CR21","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1080\/146608200300079536","volume":"1","author":"BR Brooks","year":"2000","unstructured":"Brooks BR, Miller RG, Swash M, et al. El Escorial revisited: revised criteria for the diagnosis of amyotrophic lateral sclerosis. Amyotroph Lateral Scler Other Motor Neuron Disord. 2000;1(5):293\u20139.","journal-title":"Amyotroph Lateral Scler Other Motor Neuron Disord"},{"issue":"Pt 10","key":"1033_CR22","doi-asserted-by":"publisher","first-page":"2659","DOI":"10.1093\/brain\/awp191","volume":"132","author":"I Zerr","year":"2009","unstructured":"Zerr I, Kallenberg K, Summers DM, et al. Updated clinical diagnostic criteria for sporadic Creutzfeldt-Jakob disease. Brain. 2009;132(Pt 10):2659\u201368.","journal-title":"Brain."},{"key":"1033_CR23","unstructured":"CDC\u2019s Diagnostic Criteria for Creutzfeldt-Jakob Disease (CJD), 2018. Centers for Disease Control and Prevention, National Center for Emerging and Zoonotic Infectious Diseases (NCEZID), Division of High-Consequence Pathogens and Pathology (DHCPP). Available online at: https:\/\/www.cdc.gov\/prions\/cjd\/diagnostic-criteria.html."},{"issue":"13","key":"1033_CR24","doi-asserted-by":"publisher","first-page":"1613","DOI":"10.4103\/0366-6999.235115","volume":"131","author":"LY Wu","year":"2018","unstructured":"Wu LY, Zhan SQ, Huang ZY, et al. Expert consensus on clinical diagnostic criteria for fatal familial insomnia. Chin Med J. 2018;131(13):1613\u20137.","journal-title":"Chin Med J"},{"issue":"2","key":"1033_CR25","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1007\/s00439-005-0020-1","volume":"118","author":"GG Kov\u00e1cs","year":"2005","unstructured":"Kov\u00e1cs GG, Puopolo M, Ladogana A, et al. Genetic prion disease: the EUROCJD experience. Hum Genet. 2005;118(2):166\u201374.","journal-title":"Hum Genet"},{"issue":"10","key":"1033_CR26","doi-asserted-by":"publisher","first-page":"3043","DOI":"10.1093\/brain\/awq216","volume":"133","author":"I Nozaki","year":"2010","unstructured":"Nozaki I, Hamaguchi T, Sanjo N, et al. Prospective 10-year surveillance of human prion diseases in Japan. Brain. 2010;133(10):3043\u201357.","journal-title":"Brain."},{"key":"1033_CR27","doi-asserted-by":"publisher","first-page":"699836","DOI":"10.3389\/fnagi.2021.699836","volume":"13","author":"L Liu","year":"2021","unstructured":"Liu L, Cui B, Chu M, et al. The frequency of genetic mutations associated with behavioral variant frontotemporal dementia in Chinese Han patients. Front Aging Neurosci. 2021;13:699836.","journal-title":"Front Aging Neurosci"},{"issue":"8","key":"1033_CR28","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0024231","volume":"6","author":"C Gao","year":"2011","unstructured":"Gao C, Shi Q, Tian C, et al. The epidemiological, clinical, and laboratory features of sporadic Creutzfeldt-Jakob disease patients in China: surveillance data from 2006 to 2010. PLoS One. 2011;6(8):e24231.","journal-title":"PLoS One"},{"key":"1033_CR29","doi-asserted-by":"publisher","first-page":"934","DOI":"10.3389\/fnins.2019.00934","volume":"13","author":"C Chen","year":"2019","unstructured":"Chen C, Hu C, Shi Q, et al. Profiles of 14-3-3 and total tau in CSF samples of Chinese patients of different genetic prion diseases. Front Neurosci. 2019;13:934.","journal-title":"Front Neurosci"},{"issue":"2","key":"1033_CR30","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1001\/archneur.1996.00550020074017","volume":"53","author":"BJ Steinhoff","year":"1996","unstructured":"Steinhoff BJ, R\u00e4cker S, Herrendorf G, et al. Accuracy and reliability of periodic sharp wave complexes in Creutzfeldt-Jakob disease. Arch Neurol. 1996;53(2):162\u20136.","journal-title":"Arch Neurol"},{"issue":"1-2","key":"1033_CR31","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1159\/000443205","volume":"41","author":"K Kansal","year":"2016","unstructured":"Kansal K, Mareddy M, Sloane KL, et al. Survival in frontotemporal dementia phenotypes: a meta-analysis. Dement Geriatr Cogn Disord. 2016;41(1-2):109\u201322.","journal-title":"Dement Geriatr Cogn Disord"},{"key":"1033_CR32","doi-asserted-by":"publisher","first-page":"506","DOI":"10.3389\/fnins.2019.00506","volume":"13","author":"M Ciani","year":"2019","unstructured":"Ciani M, Benussi L, Bonvicini C, et al. Genome wide association study and next generation sequencing: a glimmer of light toward new possible horizons in frontotemporal dementia research. Front Neurosci. 2019;13:506.","journal-title":"Front Neurosci"},{"issue":"18","key":"1033_CR33","doi-asserted-by":"publisher","first-page":"1736","DOI":"10.1212\/WNL.0000000000002638","volume":"86","author":"IT Coyle-Gilchrist","year":"2016","unstructured":"Coyle-Gilchrist IT, Dick KM, Patterson K, et al. Prevalence, characteristics, and survival of frontotemporal lobar degeneration syndromes. Neurology. 2016;86(18):1736\u201343.","journal-title":"Neurology."},{"issue":"11","key":"1033_CR34","doi-asserted-by":"publisher","first-page":"1411","DOI":"10.1001\/jamaneurol.2013.3956","volume":"70","author":"EM Wood","year":"2013","unstructured":"Wood EM, Falcone D, Suh E, et al. Development and validation of pedigree classification criteria for frontotemporal lobar degeneration. JAMA Neurol. 2013;70(11):1411\u20137.","journal-title":"JAMA Neurol"},{"issue":"Pt 9","key":"1033_CR35","doi-asserted-by":"publisher","first-page":"2016","DOI":"10.1093\/brain\/awg204","volume":"126","author":"SM Rosso","year":"2003","unstructured":"Rosso SM, Donker Kaat L, Baks T, et al. Frontotemporal dementia in The Netherlands: patient characteristics and prevalence estimates from a population-based study. Brain. 2003;126(Pt 9):2016\u201322.","journal-title":"Brain."},{"issue":"10004","key":"1033_CR36","doi-asserted-by":"publisher","first-page":"1672","DOI":"10.1016\/S0140-6736(15)00461-4","volume":"386","author":"J Bang","year":"2015","unstructured":"Bang J, Spina S, Miller BL. Frontotemporal dementia. Lancet. 2015;386(10004):1672\u201382.","journal-title":"Lancet."},{"issue":"4","key":"1033_CR37","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1038\/s41582-020-0330-x","volume":"16","author":"F Panza","year":"2020","unstructured":"Panza F, Lozupone M, Seripa D, et al. Development of disease-modifying drugs for frontotemporal dementia spectrum disorders. Nat Rev Neurol. 2020;16(4):213\u201328.","journal-title":"Nat Rev Neurol"},{"issue":"6333","key":"1033_CR38","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1038\/352340a0","volume":"352","author":"MS Palmer","year":"1991","unstructured":"Palmer MS, Dryden AJ, Hughes JT, et al. Homozygous prion protein genotype predisposes to sporadic Creutzfeldt-Jakob disease. Nature. 1991;352(6333):340\u20132.","journal-title":"Nature."},{"issue":"7335","key":"1033_CR39","doi-asserted-by":"publisher","first-page":"540","DOI":"10.1038\/nature09768","volume":"470","author":"MK Sandberg","year":"2011","unstructured":"Sandberg MK, Al-Doujaily H, Sharps B, et al. Prion propagation and toxicity in vivo occur in two distinct mechanistic phases. Nature. 2011;470(7335):540\u20132.","journal-title":"Nature."},{"issue":"5852","key":"1033_CR40","doi-asserted-by":"publisher","first-page":"930","DOI":"10.1126\/science.1138718","volume":"318","author":"J Collinge","year":"2007","unstructured":"Collinge J, Clarke AR. A general model of prion strains and their pathogenicity. Science. 2007;318(5852):930\u20136.","journal-title":"Science."},{"issue":"4","key":"1033_CR41","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1001\/jamaneurol.2015.4885","volume":"73","author":"S Mead","year":"2016","unstructured":"Mead S, Burnell M, Lowe J, et al. Clinical trial simulations based on genetic stratification and the natural history of a functional outcome measure in Creutzfeldt-Jakob disease. JAMA Neurol. 2016;73(4):447\u201355.","journal-title":"JAMA Neurol"},{"issue":"Pt 5","key":"1033_CR42","doi-asserted-by":"publisher","first-page":"1350","DOI":"10.1093\/brain\/awm063","volume":"130","author":"U Heinemann","year":"2007","unstructured":"Heinemann U, Krasnianski A, Meissner B, et al. Creutzfeldt-Jakob disease in Germany: a prospective 12-year surveillance. Brain. 2007;130(Pt 5):1350\u20139.","journal-title":"Brain."},{"issue":"6","key":"1033_CR43","doi-asserted-by":"publisher","first-page":"858","DOI":"10.1002\/ana.20646","volume":"58","author":"X Li","year":"2005","unstructured":"Li X, Rowland LP, Mitsumoto H, et al. Prion protein codon 129 genotype prevalence is altered in primary progressive aphasia. Ann Neurol. 2005;58(6):858\u201364.","journal-title":"Ann Neurol"},{"issue":"8","key":"1033_CR44","doi-asserted-by":"publisher","first-page":"789","DOI":"10.1097\/NEN.0b013e3181e85737","volume":"69","author":"A Alzualde","year":"2010","unstructured":"Alzualde A, Indakoetxea B, Ferrer I, et al. A novel PRNP Y218N mutation in gerstmann-str\u00e4ussler-scheinker disease with neurofibrillary degeneration. J Neuropathol Exp Neurol. 2010;69(8):789\u2013800.","journal-title":"J Neuropathol Exp Neurol"},{"issue":"4","key":"1033_CR45","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1007\/s00401-021-02350-y","volume":"142","author":"S Baiardi","year":"2021","unstructured":"Baiardi S, Rossi M, Mammana A, et al. Phenotypic diversity of genetic Creutzfeldt-Jakob disease: a histo-molecular-based classification. Acta Neuropathol. 2021;142(4):707\u201328.","journal-title":"Acta Neuropathol"},{"issue":"5","key":"1033_CR46","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1007\/s11427-006-2019-9","volume":"49","author":"J Han","year":"2006","unstructured":"Han J, Zhang J, Yao H, et al. Study on interaction between microtubule associated protein tau and prion protein. Sci China C Life Sci. 2006;49(5):473\u20139.","journal-title":"Sci China C Life Sci"},{"issue":"1","key":"1033_CR47","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1007\/s00401-010-0691-0","volume":"121","author":"L Reiniger","year":"2011","unstructured":"Reiniger L, Lukic A, Linehan J, et al. Tau, prions and A\u03b2: the triad of neurodegeneration. Acta Neuropathol. 2011;121(1):5\u201320.","journal-title":"Acta Neuropathol"},{"issue":"10","key":"1033_CR48","doi-asserted-by":"publisher","first-page":"802","DOI":"10.1016\/S1474-4422(20)30274-X","volume":"19","author":"C Condello","year":"2020","unstructured":"Condello C, DeGrado WF, Prusiner SB. Prion biology: implications for Alzheimer\u2019s disease therapeutics. Lancet Neurol. 2020;19(10):802\u20133.","journal-title":"Lancet Neurol"},{"issue":"9","key":"1033_CR49","doi-asserted-by":"publisher","first-page":"4861","DOI":"10.3390\/ijms22094861","volume":"22","author":"GA Carlson","year":"2021","unstructured":"Carlson GA, Prusiner SB. How an infection of sheep revealed prion mechanisms in Alzheimer\u2019s disease and other neurodegenerative disorders. Int J Mol Sci. 2021;22(9):4861.","journal-title":"Int J Mol Sci."}],"container-title":["Alzheimer's Research &amp; Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13195-022-01033-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13195-022-01033-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13195-022-01033-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,6,29]],"date-time":"2022-06-29T16:04:28Z","timestamp":1656518668000},"score":1,"resource":{"primary":{"URL":"https:\/\/alzres.biomedcentral.com\/articles\/10.1186\/s13195-022-01033-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6,29]]},"references-count":49,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,12]]}},"alternative-id":["1033"],"URL":"https:\/\/doi.org\/10.1186\/s13195-022-01033-4","relation":{},"ISSN":["1758-9193"],"issn-type":[{"value":"1758-9193","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,6,29]]},"assertion":[{"value":"2 January 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 June 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 June 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was approved by the Ethics Committees of the Xuanwu Hospital of Capital Medical University, and it was carried out in compliance with the Declaration of Helsinki\u2019s principles. Written informed consent was obtained from each patient or their guardian.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"90"}}